Biotechnologies consulting process development

BPD is a contract research facility, which started operations in 1996. From the storage of frozen materials, the customized laboratory services to the consulting in process development and scaling up, BPD has been accumulating useful experiences in the biotechnological scenario. Very flexible set of fermenters are used to satisfy customer needs, through very small and fast adaptation and modifications. Bioreactors productivity varies from 100 mg to 1000 mg scale. 

Joaima Chataway is Director of the Irmovation, Health and Science Group at RAND Europe, a not-for-profit policy research institute, and Professor of Biotechnology and Development at the Open University. She has held senior positions and appointments across a range of academic, policy research, consulting and research funding bodies. She has particular expertise in the field of health innovation and has researched extensively the range of factors that influence the rate and direction of product and process innovation in health. 

In light of this interpenetration of laboratory work and industrial production, it should be easy to see that the schema of pure and apphed chemistry is illusory in a number of respects. In particular, it presents an image of a one-way flow from the development of a synthesis based on the theory of the pure science to its application in an industrial production process. Even before this distinction was declared obsolete by the rise of the biotechnologies and other approaches that supposedly blurred the boundaries, a two-way exchange between industrial practice and university research had always existed. A large number of nineteenth-century chemists received their training as apprentices in one of the chemical arts, and while generally not a source of pride for university chemists at that time, many supplemented their incomes as consultants for industry. 

---